FHTX
Foghorn Therapeutics Inc
2.10$
+6.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.4% | -2.0% | -4.2% | -12.5% | +8.7% | +8.7% | +2.9% | +5.8% | -5.4% | -72.0% | -3.4% | – | |
| – | -25.5% | +5.7% | -1.7% | -4.7% | -17.7% | +8.4% | +1.5% | +0.0% | -18.0% | +6.3% | +7.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -54.9% | +173.0% | -83.2% | +1,717.6% | +55.0% | -94.2% | -21.4% | -100.0% | – | – | – | – | |
| – | -2.7% | -27.5% | -166.3% | +241.1% | – | +31.9% | +15.1% | +5.1% | -62.8% | -233.9% | -83.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -86.6% | +527.4% | +8,743.7% | -99.0% | -99.6% | +3,375.0% | +82.7% | -80.7% | +1,085.7% | +8,466.6% | -200.0% | – | |
| – | -20.4% | -110.8% | – | -236.1% | – | – | +129.6% | +31.0% | -150.5% | – | -1,155.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.